JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99904

Goat Anti-Mouse IgE (SureLight® APC)

Be the first to review this product! Submit a review

|

(0 Publication)

Suitable for Flow Cyt.

View Alternative Names

Immunoglobulin heavy constant epsilon, Ig epsilon chain C region, IGHE

Key facts

Host species

Goat

Minimal cross-reactivity
Conjugation

SureLight® APC

Excitation/Emission

Ex: 652nm, Em: 657nm

Applications

Flow Cyt

applications

Clonality

Polyclonal

Isotype

IgG

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Flow Cyt": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"3 µg/mL", "notes":"" } } }

Properties and storage information

Form
Lyophilized
Reconstitution
reconstitute with water at 1mL
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 8.2 Constituents: 1.71% Sucrose, 0.87% Sodium chloride, 0.121% Tris, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.
See full target information IGHE

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com